Neurology
News
FDA approves first drug to treat Alzheimer’s agitation
“Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease.”
News
Hearing aids are a ‘powerful’ tool for reducing dementia risk
“The evidence is building that hearing loss may be the most impactful modifiable risk factor for dementia in mid-life.”
News
AHA backs screening for cognitive impairment after stroke
Cognitive impairment is common after a stroke; screening may help detect it early and allow appropriate multidisciplinary care, AHA says.
Conference Coverage
Head-to-head comparison of migraine meds reveals top options
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
Conference Coverage
Oral antiamyloid shows disease-modifying potential Phase 3 trial underway
Phase 2 data showed that use of the drug resulted in positive changes in plasma and imaging biomarkers of Alzheimer’s disease pathology.
News
FDA expands atogepant approval to include chronic migraine
The approval makes atogepant the first, and only, oral CGRP receptor antagonist approved to prevent migraine across frequencies, including...
Conference Coverage
Donanemab bests aducanumab in head-to-head Alzheimer’s trial
Nearly 40% of patients treated with donanemab had amyloid clearance at 6 months compared with less than 2% of those who received aducanumab.
Conference Coverage
New hope for adult children with ‘failure to launch’ syndrome
The novel program focuses on reducing parents’ family accommodation, a descriptor for a child’s excessive dependence on their parents to help them...
Conference Coverage
Cautious optimism for new Alzheimer’s disease biomarkers and treatments, expert says
“The greatest challenge is cost, as blood-based biomarkers are not currently covered by insurance and still rather costly.”
News
Unawareness of memory slips could indicate risk for Alzheimer’s
Over an 11-year study the people who declined in cognitive function were less aware of slips in their memory.